“…The above results were obtained with the telomeric and the hTERT promoter sequences. However, G4 DNAs can be formed from DNA sequences found in the promoter region of several oncogenes, including c-Myc , VEGF , BCL-2 , c-KIT , c-MYB , HIF-1α , HRAS , KRAS , PDGF-A , PDGFR-β , RET , and SRC ; these sites are potential targets for anticancer therapy by G4 ligands. − The structural variations of G4 are diverse, and specific G4 ligands can explicitly bind one topology, among others. , To investigate whether our three PDIs could differentially interact with different G4 DNAs at these three pHs (pH 6–8), we employed a duplex–quadruplex competition assay with two more sequences, the c-Myc promoter and VEGF promoter sequences. The results are shown in Figure S4, Supporting Information.…”